TricodeGF (Respa Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Tricode drug offered from Respa Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Respa Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride
SUBSTANCE NAME: CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-06-20
END MARKETING DATE: 0000-00-00


Tricode GF HUMAN OTC DRUG Details:

Item DescriptionTricode GF from Respa Pharmaceuticals, Inc.
LABELER NAME: Respa Pharmaceuticals, Inc.
DEA SCHEDULE: CV
ACTIVE STRENGTH: 8; 200; 30(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2011-06-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60575-414_ba3af78f-2f38-48c7-94bf-36416da895a5
PRODUCT NDC: 60575-414
APPLICATION NUMBER: part341

Other CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Glendale IncCoditussin DAC
Llorens Pharmaceutical International DivisionTusnel
Respa Pharmaceuticals, Inc.Tricode
Sallus Laboratories, LLCLORTUSS
Virtus PharmaceuticalsVirtussin DAC